Dentsply Sirona (XRAY) Tops Q3 EPS by 7c, Revenues Beat; Raises FY19 EPS Guidance, Confirms FY19 Revenue Outlook
Dentsply Sirona (NASDAQ: XRAY) reported Q3 EPS of $0.57, $0.07 better than the analyst estimate of $0.50. Revenue for the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
